These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6311964)

  • 1. Opsonization of alphaviruses in hamsters.
    Jahrling PB; Hesse RA; Anderson AO; Gangemi JD
    J Med Virol; 1983; 12(1):1-16. PubMed ID: 6311964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protective immunity between equine encephalomyelitis viruses in equids.
    Walton TE; Jochim MM; Barber TL; Thompson LH
    Am J Vet Res; 1989 Sep; 50(9):1442-6. PubMed ID: 2552875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN/VEE viruses.
    Paessler S; Ni H; Petrakova O; Fayzulin RZ; Yun N; Anishchenko M; Weaver SC; Frolov I
    J Virol; 2006 Mar; 80(6):2784-96. PubMed ID: 16501087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.
    Rico AB; Phillips AT; Schountz T; Jarvis DL; Tjalkens RB; Powers AM; Olson KE
    Virology; 2016 Dec; 499():30-39. PubMed ID: 27632563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
    Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
    Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the murine T helper cell immune response to various alphaviruses.
    Mathews JH; Roehrig JT
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2877-86. PubMed ID: 2479713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early protection in hamsters immunized with attenuated Venezuelan equine encephalomyelitis vaccine.
    Cole FE; Pedersen CE; Robinson DM
    Appl Microbiol; 1972 Oct; 24(4):604-8. PubMed ID: 5086903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of homologous and heterologous antibody response in California horses vaccinated with attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
    Ferguson JA; Reeves WC; Milby MM; Hardy JL
    Am J Vet Res; 1978 Mar; 39(3):371-6. PubMed ID: 637386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection in hamsters immunized with group A arbovirus vaccines.
    Cole FE; McKinney RW
    Infect Immun; 1971 Jul; 4(1):37-43. PubMed ID: 5154876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune interference after sequential alphavirus vaccine vaccinations.
    Pittman PR; Liu CT; Cannon TL; Mangiafico JA; Gibbs PH
    Vaccine; 2009 Aug; 27(36):4879-82. PubMed ID: 19576665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arbovirus studies in the Guajira region of Venezuela: activities of eastern equine encephalitis and Venezuelan equine encephalitis viruses during an interepizootic period.
    Walder R; Suarez OM; Calisher CH
    Am J Trop Med Hyg; 1984 Jul; 33(4):699-707. PubMed ID: 6148023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of Venezuelan equine encephalitis virus infection in mice and hamsters.
    Jackson AC; SenGupta SK; Smith JF
    Vet Pathol; 1991 Sep; 28(5):410-8. PubMed ID: 1750167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates.
    Turell MJ; Ludwig GV; Kondig J; Smith JF
    Am J Trop Med Hyg; 1999 Jun; 60(6):1041-4. PubMed ID: 10403340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venezuelan equine encephalomyelitis vaccine (strain TC-83): a field study.
    Baker EF; Sasso DR; Maness K; Prichard WD; Parker RL
    Am J Vet Res; 1978 Oct; 39(10):1627-31. PubMed ID: 717877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84).
    Edelman R; Ascher MS; Oster CN; Ramsburg HH; Cole FE; Eddy GA
    J Infect Dis; 1979 Nov; 140(5):708-15. PubMed ID: 528788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective clearance of a benign clone of Venezuelan equine encephalitis virus from hamster plasma by hepatic reticuloendothelial cells.
    Jahrling PB; Gorelkin L
    J Infect Dis; 1975 Dec; 132(6):667-76. PubMed ID: 1202111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arbovirus investigations in Argentina, 1977-1980. IV. Serologic surveys and sentinel equine program.
    Monath TP; Sabattini MS; Pauli R; Daffner JF; Mitchell CJ; Bowen GS; Cropp CB
    Am J Trop Med Hyg; 1985 Sep; 34(5):966-75. PubMed ID: 2863991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.